Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study
The secretome obtained from stem cell cultures contains an array of neurotrophic factors and cytokines that might have the potential to treat neurodegenerative conditions. Alzheimer’s disease (AD) is one of the most common human late onset and sporadic neurodegenerative disorders. Here, we investiga...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/8102478 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566923338973184 |
|---|---|
| author | Nermeen El-Moataz Bellah Ahmed Masashi Murakami Yujiro Hirose Misako Nakashima |
| author_facet | Nermeen El-Moataz Bellah Ahmed Masashi Murakami Yujiro Hirose Misako Nakashima |
| author_sort | Nermeen El-Moataz Bellah Ahmed |
| collection | DOAJ |
| description | The secretome obtained from stem cell cultures contains an array of neurotrophic factors and cytokines that might have the potential to treat neurodegenerative conditions. Alzheimer’s disease (AD) is one of the most common human late onset and sporadic neurodegenerative disorders. Here, we investigated the therapeutic potential of secretome derived from dental pulp stem cells (DPSCs) to reduce cytotoxicity and apoptosis caused by amyloid beta (Aβ) peptide. We determined whether DPSCs can secrete the Aβ-degrading enzyme, neprilysin (NEP), and evaluated the effects of NEP expression in vitro by quantitating Aβ-degrading activity. The results showed that DPSC secretome contains higher concentrations of VEGF, Fractalkine, RANTES, MCP-1, and GM-CSF compared to those of bone marrow and adipose stem cells. Moreover, treatment with DPSC secretome significantly decreased the cytotoxicity of Aβ peptide by increasing cell viability compared to nontreated cells. In addition, DPSC secretome stimulated the endogenous survival factor Bcl-2 and decreased the apoptotic regulator Bax. Furthermore, neprilysin enzyme was detected in DPSC secretome and succeeded in degrading Aβ1–42 in vitro in 12 hours. In conclusion, our study demonstrates that DPSCs may serve as a promising source for secretome-based treatment of Alzheimer’s disease. |
| format | Article |
| id | doaj-art-dc9011e73f8845ed8582a6f3ab67602b |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-dc9011e73f8845ed8582a6f3ab67602b2025-02-03T01:02:53ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/81024788102478Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro StudyNermeen El-Moataz Bellah Ahmed0Masashi Murakami1Yujiro Hirose2Misako Nakashima3Department of Stem Cell Biology and Regenerative Medicine, National Center for Geriatrics and Gerontology, Research Institute, Obu, Aichi 474-8511, JapanDepartment of Stem Cell Biology and Regenerative Medicine, National Center for Geriatrics and Gerontology, Research Institute, Obu, Aichi 474-8511, JapanDepartment of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Osaka 565-0871, JapanDepartment of Stem Cell Biology and Regenerative Medicine, National Center for Geriatrics and Gerontology, Research Institute, Obu, Aichi 474-8511, JapanThe secretome obtained from stem cell cultures contains an array of neurotrophic factors and cytokines that might have the potential to treat neurodegenerative conditions. Alzheimer’s disease (AD) is one of the most common human late onset and sporadic neurodegenerative disorders. Here, we investigated the therapeutic potential of secretome derived from dental pulp stem cells (DPSCs) to reduce cytotoxicity and apoptosis caused by amyloid beta (Aβ) peptide. We determined whether DPSCs can secrete the Aβ-degrading enzyme, neprilysin (NEP), and evaluated the effects of NEP expression in vitro by quantitating Aβ-degrading activity. The results showed that DPSC secretome contains higher concentrations of VEGF, Fractalkine, RANTES, MCP-1, and GM-CSF compared to those of bone marrow and adipose stem cells. Moreover, treatment with DPSC secretome significantly decreased the cytotoxicity of Aβ peptide by increasing cell viability compared to nontreated cells. In addition, DPSC secretome stimulated the endogenous survival factor Bcl-2 and decreased the apoptotic regulator Bax. Furthermore, neprilysin enzyme was detected in DPSC secretome and succeeded in degrading Aβ1–42 in vitro in 12 hours. In conclusion, our study demonstrates that DPSCs may serve as a promising source for secretome-based treatment of Alzheimer’s disease.http://dx.doi.org/10.1155/2016/8102478 |
| spellingShingle | Nermeen El-Moataz Bellah Ahmed Masashi Murakami Yujiro Hirose Misako Nakashima Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study Stem Cells International |
| title | Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study |
| title_full | Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study |
| title_fullStr | Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study |
| title_full_unstemmed | Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study |
| title_short | Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study |
| title_sort | therapeutic potential of dental pulp stem cell secretome for alzheimer s disease treatment an in vitro study |
| url | http://dx.doi.org/10.1155/2016/8102478 |
| work_keys_str_mv | AT nermeenelmoatazbellahahmed therapeuticpotentialofdentalpulpstemcellsecretomeforalzheimersdiseasetreatmentaninvitrostudy AT masashimurakami therapeuticpotentialofdentalpulpstemcellsecretomeforalzheimersdiseasetreatmentaninvitrostudy AT yujirohirose therapeuticpotentialofdentalpulpstemcellsecretomeforalzheimersdiseasetreatmentaninvitrostudy AT misakonakashima therapeuticpotentialofdentalpulpstemcellsecretomeforalzheimersdiseasetreatmentaninvitrostudy |